Harrow, Inc. (HROW)
34.53
+0.05
(+0.15%)
USD |
NASDAQ |
Sep 14, 12:58
Harrow Price to Book Value : 85.15 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 85.03 |
| September 10, 2026 | 90.21 |
| September 09, 2026 | 92.60 |
| September 08, 2026 | 93.34 |
| September 04, 2026 | 95.04 |
| September 03, 2026 | 94.35 |
| September 02, 2026 | 96.30 |
| September 01, 2026 | 91.17 |
| August 31, 2026 | 91.02 |
| August 28, 2026 | 91.91 |
| August 27, 2026 | 95.04 |
| August 26, 2026 | 96.99 |
| August 25, 2026 | 101.92 |
| August 24, 2026 | 98.15 |
| August 21, 2026 | 100.99 |
| August 20, 2026 | 103.72 |
| August 19, 2026 | 102.69 |
| August 18, 2026 | 97.46 |
| August 17, 2026 | 97.35 |
| August 14, 2026 | 98.72 |
| August 13, 2026 | 95.86 |
| August 12, 2026 | 97.06 |
| August 11, 2026 | 97.21 |
| August 10, 2026 | 100.37 |
| August 07, 2026 | 99.73 |
| Date | Value |
|---|---|
| August 06, 2026 | 98.45 |
| August 05, 2026 | 97.19 |
| August 04, 2026 | 98.22 |
| August 03, 2026 | 96.40 |
| July 31, 2026 | 95.61 |
| July 30, 2026 | 96.03 |
| July 29, 2026 | 95.39 |
| July 28, 2026 | 96.97 |
| July 27, 2026 | 92.38 |
| July 24, 2026 | 94.82 |
| July 23, 2026 | 103.28 |
| July 22, 2026 | 105.62 |
| July 21, 2026 | 107.79 |
| July 20, 2026 | 109.62 |
| July 17, 2026 | 115.04 |
| July 16, 2026 | 110.68 |
| July 15, 2026 | 105.87 |
| July 14, 2026 | 102.02 |
| July 13, 2026 | 103.11 |
| July 10, 2026 | 104.76 |
| July 09, 2026 | 105.87 |
| July 08, 2026 | 111.15 |
| July 07, 2026 | 113.81 |
| July 06, 2026 | 110.80 |
| July 02, 2026 | 105.40 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viatris, Inc. | 1.359 |
| Zevra Therapeutics, Inc. | 3.283 |
| 60 Degrees Pharmaceuticals, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 2.760 |
| Corcept Therapeutics, Inc. | 17.32 |
Price to Book Value Related Metrics
| PS Ratio | 4.720 |
| PEG Ratio | -0.1457 |
| Price | 34.53 |
| Earnings Yield | -2.89% |
| Market Cap | 1.294B |
| PEGY Ratio | -0.1457 |
| Operating PE Ratio | 228.17 |